Johnson & Johnson seeks regulator nod for trail of COVID-19 vaccine on 12-17 age group in India

Johnson & Johnson has sought approval of the Central Drugs Standard Control Organisation (CDSCO) to conduct a study of its vaccine against the COVID-19 disease in India among adolescents aged 12-17 years.

from Zee News :India National https://ift.tt/3j2amPN